Cinfa Group

Cinfa is part of Infarco, a parent company for several firms that handle different business lines in the world of health, and which have gradually been formed to make what is now Cinfa Group.

The Group currently has 2,000 employees and is undergoing a process of international diversification and expansion with participation in companies of different countries.


Other companies in Cinfa Group

Orliman, leader in orthopaedics

For 25 years Orliman has been  investigating, developing, manufacturing and selling products to prevent injuries, for rehabilitation and for treating chronic problems related to mobility.

A European point of reference for orthopaedic solutions, it holds a solid position in France and Spain, and it operates in over 50 countries in all five continents.

Natural Santé, developer of nutritional supplements

Created in 1986 and with a major presence in the French market, Natural Santé is a company that specialises in the development and marketing of nutritional supplements, medical devices and products based on medicinal plants.

It currently has three leading brands corresponding to its different business lines and occupies a front ranking position in over 5,000 pharmacies in France.

Santé Verte:

Plantes Laboratoire:

Diet Horizon:

Sakura Italia, specialist in healthcare

An Italian firm that commenced in 2004, Sakura has an extensive portfolio of innovative healthcare products and nutritional supplements that it markets in over 24 countries in Europe, Asia and the Middle East.

Its range of healthcare products includes almost 40 products geared towards six therapeutic areas: gynaecology, the immune system, circulation, digestion, respiratory medicine and skin care, which occupy a strong position in pharmacies.

Cyndea Pharma, specialist in hormonal therapies

Cyndea Pharma is a pharmaceutical laboratory located in Ólvega (Soria), leader in the manufacture of hormonal therapies.

Cyndea Pharma currently develops and manufactures steroid-based medications and oncology treatment for hormone-dependent tumours (e.g. breast cancer, endometrial cancer, uterine cancer or prostate cancer). And it makes use of specific technology for manufacturing soft gelatine capsules.

Cinfa Innova, R+D Centre

Cinfa Innova, the Cinfa R&D Innovation Centre, developes specialised medication at an international level for women and men’s health, oncology, and endocrinology, among other areas.

Located in Madrid, it has teams of experts in the different development phases of highly-complex generic medicinal products. The medicines developed at Cinfa Innova are marketed in different countries around the world.

In addition to developing medicinal products with the highest quality standards, Cinfa Innova has implemented differential technologies that provide added value to their products, such as soft-gelatine capsules or multi-layer tablets.